文献速递临床试验与 GCP流行病学与生物统计

加纳HIV感染女性宫颈癌筛查中HPV自采样的实施:混合1型效果-实施随机对照试验方案

HPV self-sampling for cervical cancer screening among women living with HIV in Ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial.
PubMed 文献 · Trials · 2025-11-26

本研究为在加纳海岸角教学医院开展的混合1型效果-实施随机对照试验,纳入108名HIV感染女性,随机分为HOPE干预组(HPV自采样联合3R信息)或标准护理对照组,主要评价HOPE工具包提高宫颈癌筛查率的效果,并评估可行性、可接受性、适宜性和可采纳性及实施影响因素。

要点

  • 研究纳入108名HIV感染女性,随机分为HOPE干预组与标准护理对照组。
  • HOPE干预包括HPV自采样和3R沟通模式(重新构建、重新优先、改革)。
  • 主要目的是评价HOPE工具包提高宫颈癌筛查率的效果,并评估实施相关指标。

核心结论

  • 本研究旨在评价HOPE工具包在加纳HIV感染女性中提高宫颈癌筛查率的效果,并评估其可行性、可接受性、适宜性和可采纳性及实施影响因素。

研究设计与样本

  • 在加纳海岸角教学医院开展的混合1型效果-实施随机对照试验,共108名HIV感染女性随机分为HOPE干预组或标准护理对照组。
  • 数据通过结构化问卷、关键知情人访谈和焦点小组讨论收集,并设立由HIV感染女性、医疗服务提供者和社区成员组成利益相关者咨询委员会通过名义群体技术共同开发并调整干预。

关键数值与推荐

  • HOPE干预组接受HPV自采样和3R信息(重新构建、重新优先、改革),对照组接受标准护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women living with HIV (WLWH) face a significantly higher risk of developing cervical cancer (CC) due to immune system suppression, which impairs the body's ability to clear high-risk HPV infections. Despite this increased risk, cervical cancer screening rates remain low among WLWH in Ghana, hindered by financial, logistical, and cultural barriers. Evidence-based interventions, such as HPV self-sampling and the 3R communication model (reframe, reprioritize, and reform) offer promising strategies to improve screening uptake. The primary objective of this study was to evaluate the effectiveness of the Home-based self-sampling for cervical cancer Prevention Education (HOPE) toolkit in increasing CC screening among WLWH in Ghana. Secondary objectives include assessing the feasibility, acceptability, appropriateness and adoptability of the HOPE intervention, as well as identifying key factors that influence its implementation. METHODS: The study will be conducted at the Cape Coast Teaching Hospital (CCTH) in Ghana, using a Hybrid Type 1 effectiveness-implementation randomized controlled trial (RCT) design. A total of 108 WLWH will be randomly assigned to either the HOPE intervention group, which includes HPV self-sampling and 3R messaging, or a control group receiving standard care. Data will be collected through structured surveys, key informant interviews, and focus group discussions. The study will also engage a stakeholder advisory board (SAB) comprising WLWH, healthcare providers and community members to co-develop and adapt the intervention through nominal group technique. DISCUSSION: By leveraging existing healthcare infrastructure and community engagement, this study seeks to provide a scalable, evidence-based approach to improving CC screening among WLWH in Ghana. Findings will inform national strategies for integrating HPV self-sampling and health communication interventions to enhance early detection and reduce cervical cancer-related morbidity and mortality in this high-risk population. TRIAL REGISTRATION: ClinicalTrials.gov NCT06739772. Registered on 18 December 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Asare M, Obiri-Yeboah D, Ken-Amoah S, et al. HPV self-sampling for cervical cancer screening among women living with HIV in Ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial. Trials. 2025. PMID: 41299750. doi:10.1186/s13063-025-09262-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。